Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Retatrutide is an investigational once-weekly triple agonist that targets GLP-1, GIP, and glucagon receptors
Related Stories GLP-1 receptor activation linked to lower depression and bipolar disorder odds GLP-1RAs linked to lower risk of amputation in diabetes with PAD Thymulin curbs age-related inflammation and slows breast tumors in mice GLP-1 RA exposure (exenatide, dulaglutide, liraglutide, semaglutide) was assessed over 30-day risk and reference periods, separated by a 60-day washout
Taking a GLP-1 medication plus a hypothetical GIP medication separately wouldnt necessarily produce the same effects as a designed dual agonist, and this approach hasnt been studied
GLP-1 patches vs GLP-1 injections Why you should choose GLP-1 injections over patches If you're thinking about losing weight, it makes sense to go with what's actually been proven to work
US$ 23.26
US$ 27.08
US$ 23.75
US$ 23.01
US$ 28.32
